The outbreak of mpox in the DRC has escalated significantly, with nearly 20,000 suspected cases and over 650 deaths reported in 2024, prompting urgent international response.
Clade I of mpox is more virulent than Clade II, with a higher mortality rate and severe illness, raising alarms beyond Central and West Africa.
U.S. officials highlighted the urgency of the situation, stating: 'In 2023, [the DRC] reported more than 14,000 suspected cases and more than 650 deaths.' This year, early reports show no signs of relief.
The U.S. government has committed $55 million in additional funding to mpox response efforts in Central and Eastern Africa, continuing its extensive support for the region.
Collection
[
|
...
]